Risperidone, marketed under the trade name RISPERDAL®, is an atypical antipsychotic medication that was first approved by the US Food and Drug Administration (FDA) on December 29, 1993.

Diltiazem,sold under the brand name Cardizem among others, is a calcium ion cellular influx inhibitor (slow channel blocker or calcium antagonist).

Levofloxacin is an effective synthetic antibiotic for treating various bacterial infections, including those affecting the respiratory and urinary tracts, skin, soft tissues, and prostate.

Sumatriptan is a small molecule drug and developed by GSK. Its first approved in 1996 in the USA.

Modafinil, a minuscule molecular compound marketed as PROVIGIL, received its initial approval in 1992.

Paroxetine, a small molecule drug, is a serotonin reuptake inhibitors (SSRIs) .

Donepezil, a small molecule, acts as an acetylcholinesterase inhibitor, preventing the breakdown of the neurotransmitter acetylcholine in the brain, thus helping improve cognition.

Phenylephrine, a small drug molecule, acts as an alpha-1 adrenergic receptor agonist to help dilate the pupil for eye exams and surgeries.

Metoclopramide, marketed under the brand name REGLAN®, is a small molecule drug that acts as a dopamine-2 (D2) antagonist.

Mupirocin, also known by its brand name CENTANY®, is a small molecule drug that works as an RNA synthetase inhibitor to treat bacterial infections.

Oxybutynin, marketed as DITROPAN®, is a medication approved by the US FDA in 1975 for the treatment of overactive bladder.

Dextromethorphan (DXM) is a synthetic analog of codeine, but unlike codeine, it is not a narcotic and does not have the same potential for abuse or addiction.